Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Opie, LH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 130 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Roverkamp, BT; Minners, J; Opie, LH
      Opioid preconditioning extends to post-ischemic recovery of contractile function as shown with a novel opioid delta selective agonist, SB 235863A, that acts on the mitochondrial K-ATP channel

      CARDIOVASCULAR DRUGS AND THERAPY
    2. Opie, LH
      Calcium channel blockers in hypertension: Reappraisal after new trials andmajor meta-analyses

      AMERICAN JOURNAL OF HYPERTENSION
    3. Schwalb, H; Olivson, A; Li, J; Houminer, E; Wahezi, SE; Opie, LH; Maulik, D; Borman, JB; Powell, SR
      Nicorandil decreases postischemic actin oxidation

      FREE RADICAL BIOLOGY AND MEDICINE
    4. Jaberansari, MT; Baxter, GF; Muller, CA; Latouf, SE; Roth, E; Opie, LH; Yellon, DM
      Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    5. Opie, LH; Messerli, FH
      The choice of first-line therapy: combinations of an angiotensin rationalefor low-dose converting enzyme inhibitor and a diuretic

      JOURNAL OF HYPERTENSION
    6. Rayner, BL; Myers, JE; Opie, LH; Trinder, YA; Davidson, JS
      Screening for primary aldosteronism - Normal ranges for aldosterone and renin in three South African population groups

      SOUTH AFRICAN MEDICAL JOURNAL
    7. Du Toit, EF; Meiring, J; Opie, LH
      Relation of cyclic nucleotide ratios to ischemic and reperfusion injury innitric oxide-donor treated rat hearts

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    8. Rochette, L; Moreau, D; Opie, LH
      Effect of repeated regional myocardial ischemia in the rat heart on reperfusion arrhythmias and release of norepinephrine

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    9. Opie, LH
      Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension

      LANCET
    10. Opie, LH
      Blood-pressure-lowering treatment

      LANCET
    11. Opie, LH; Sack, MN
      Enhanced angiotensin II activity in heart failure - Reevaluation of the counterregulatory hypothesis of receptor subtypes

      CIRCULATION RESEARCH
    12. Opie, LH
      Diuretic downsides - But in low doses they still seem among the best authenticated antihypertensives

      CARDIOVASCULAR DRUGS AND THERAPY
    13. Bell, SP; Sack, MN; Patel, A; Opie, LH; Yellon, DM
      Delta opioid receptor stimulation mimics ischemic preconditioning in humanheart muscle

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    14. Opie, LH
      First line drugs in chronic stable effort angina - The case for newer, longer-acting calcium channel blocking agents

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    15. Aitchison, KA; Baxter, GF; Awan, MM; Smith, RM; Yellon, DM; Opie, LH
      Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning

      BASIC RESEARCH IN CARDIOLOGY
    16. Awan, MM; Makaula, S; Forresti, S; Sack, MM; Opie, LH
      Mechanisms whereby glucose deprivation triggers metabolic preconditioning in the isolated rat heart

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    17. Rayner, BL; Opie, LH; Davidson, JS
      The aldosterone/renin ratio as a screening test for primary aldosteronism

      SOUTH AFRICAN MEDICAL JOURNAL
    18. Opie, LH
      Adverse cardiovascular drug interactions

      CURRENT PROBLEMS IN CARDIOLOGY
    19. Opie, LH; Yusuf, S; Kubler, W
      Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: A critical analysis based on 100 studies

      PROGRESS IN CARDIOVASCULAR DISEASES
    20. Opie, LH
      Calcium channel blockers and preconditioning

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    21. Opie, LH
      Trends in antihypertensive drug treatment

      CIRCULATION
    22. Minners, J; van den Bos, EJ; Yellon, DM; Schwalb, H; Opie, LH; Sack, MN
      Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprorection

      CARDIOVASCULAR RESEARCH
    23. Sack, MN; Smith, RM; Opie, LH
      Tumor necrosis factor in myocardial hypertrophy and ischaemia - an anti-apoptotic perspective

      CARDIOVASCULAR RESEARCH
    24. Opie, LH
      Dr. Stanley H. Taylor - In memoriam

      CARDIOVASCULAR DRUGS AND THERAPY
    25. Apstein, CS; Opie, LH
      Glucose-insulin-potassium (GIK) for acute myocardial infarction: A negative study with a positive value

      CARDIOVASCULAR DRUGS AND THERAPY
    26. Opie, LH
      Proof that glucose-insulin-potassium provides metabolic protection of ischaemic myocardium?

      LANCET
    27. Du Toit, EF; Muller, CA; McCarthy, J; Opie, LH
      Levosimendan: Effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    28. Awan, MM; Taunyane, C; Aitchison, KA; Yellon, DM; Opie, LH
      Normothermic transfer times up to 3 min will not precondition the isolatedrat heart

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    29. Opie, LH
      Cardiac metabolism in ischemic heart disease

      ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX
    30. OPIE LH
      PERSONAL VIEWPOINT - NEW DEVELOPMENTS IN THE THERAPY OF DIABETIC HYPERTENSIVE DISEASE - THE ABCD STUDY ADDS TO STRONG EVIDENCE FAVORING THEPRIME USE OF ACE-INHIBITORS

      Cardiovascular drugs and therapy
    31. Opie, LH
      Principles of combination therapy for hypertension: What we learn from theHOT and other studies

      CARDIOVASCULAR DRUGS AND THERAPY
    32. Muller, CA; Opie, LH; Pineda, CA; McCarthy, J; Kraljevic, V
      Combination of a calcium antagonist verapamil with an angiotensin converting enzyme inhibitor, trandolapril in experimental myocardial ischemia and reperfusion: Antiarrhythmic and hemodynamic effects of chronic oral pretreatment

      CARDIOVASCULAR DRUGS AND THERAPY
    33. MULLER CA; OPIE LH; MCCARTHY J; HOFMANN D; PINEDA CA; PEISACH M
      EFFECTS OF MIBEFRADIL, A NOVEL CALCIUM-CHANNEL BLOCKING-AGENT WITH T-TYPE ACTIVITY, IN ACUTE EXPERIMENTAL MYOCARDIAL-ISCHEMIA - MAINTENANCEOF VENTRICULAR-FIBRILLATION THRESHOLD WITHOUT INOTROPIC COMPROMISE

      Journal of the American College of Cardiology
    34. OPIE LH
      UNTITLED

      Basic research in cardiology
    35. OPIE LH
      MYOCARDIAL STUNNING - WE DO NOT KNOW THE MECHANISM NOR IS THERE OVERWHELMING EVIDENCE FOR A MAJOR ROLE OF FREE-RADICALS

      Basic research in cardiology
    36. KING LM; OPIE LH
      GLUCOSE AND GLYCOGEN UTILIZATION IN MYOCARDIAL-ISCHEMIA - CHANGES IN METABOLISM AND CONSEQUENCES FOR THE MYOCYTE

      Molecular and cellular biochemistry
    37. OPIE LH
      TRENDS IN PRESCRIBING CALCIUM-CHANNEL BLOCKERS

      Lancet
    38. OPIE LH
      JNC VI GUIDELINES

      Lancet
    39. DUTOIT EF; OPIE LH; BRUNNER F
      ROLE OF NITRIC-OXIDE CGMP PATHWAY IN EXPERIMENTAL, ISCHEMIA-REPERFUSION INJURY OF RAT HEARTS

      Naunyn-Schmiedeberg's archives of pharmacology
    40. BELL SP; SACK MN; PATEL A; OPIE LH; YELLON DM
      DELTA-OPIOID RECEPTOR STIMULATION MIMICS ISCHEMIC PRECONDITIONING IN HUMAN HEART-MUSCLE

      Circulation
    41. BAXTER GF; MULLER CA; LATOUF SE; MCCARTHY J; OPIE LH; YELLON DM
      BRIEF CORONARY-ARTERY OCCLUSIONS BY INTRACORONARY BALLOON INFLATION INDUCE DELAYED PRECONDITIONING AGAINST INFARCTION IN PIG MYOCARDIUM

      Circulation
    42. BRUNNER F; OPIE LH
      ROLE OF ENDOTHELIN-A RECEPTORS IN ISCHEMIC CONTRACTURE AND REPERFUSION INJURY

      Circulation
    43. KING LM; OPIE LH
      GLUCOSE DELIVERY IS A MAJOR DETERMINANT OF GLUCOSE-UTILIZATION IN THEISCHEMIC MYOCARDIUM WITH A RESIDUAL CORONARY FLOW

      Cardiovascular Research
    44. AITCHISON KA; BAXTER GF; YELLON DM; OPIE LH
      INVOLVEMENT OF DELTA-OPIOID RECEPTOR SUBTYPES IN ISCHEMIC PRECONDITIONING AGAINST INFARCTION IN THE RAT ISOLATED HEART

      British Journal of Pharmacology
    45. DUTOIT EF; MCCARTHY J; MIYASHIRO J; OPIE LH; BRUNNER F
      EFFECT OF NITROVASODILATORS AND INHIBITORS OF NITRIC-OXIDE SYNTHASE ON ISCHEMIC AND REPERFUSION FUNCTION OF RAT ISOLATED HEARTS

      British Journal of Pharmacology
    46. OPIE LH
      REVIEW OF TRIALS IN THE TREATMENT OF CORONARY-ARTERY-DISEASE - THEORETICAL EXPECTATIONS VERSUS LACK OF PRACTICAL SUCCESS - HOW CAN WE EXPLAIN THE DIFFERENCES

      The American journal of cardiology
    47. OPIE LH
      EVIDENCE IS NEEDED THAT BETA-BLOCKADE ALONE REDUCES MORTALITY IN HYPERTENSION

      BMJ. British medical journal
    48. OPIE LH
      COMMENTARY - CALCIUM-ANTAGONIST CONTROVERSY, DOES THE ACCUSING FINGERALSO POINT TO BETA-BLOCKERS AND METHYLDOPA

      Journal of human hypertension
    49. OPIE LH
      NEW DEVELOPMENTS IN CARDIOVASCULAR DRUGS - VITAMIN-E AND ANTIOXIDANTS- AN INFORMAL AND PERSONAL VIEWPOINT

      Cardiovascular drugs and therapy
    50. OPIE LH
      NEW DEVELOPMENTS IN CARDIOVASCULAR DRUGS - HEART-FAILURE - AN INFORMED AND PERSONAL VIEWPOINT

      Cardiovascular drugs and therapy
    51. OPIE LH; RAPPAPORT E
      7TH INTERNATIONAL-SYMPOSIUM ON CARDIOVASCULAR PHARMACOTHERAPY - JERUSALEM, ISRAEL, JUNE 1-6, 1997 - INTRODUCTION

      Cardiovascular drugs and therapy
    52. OPIE LH
      CALCIUM-CHANNEL BLOCKERS - SUMMARY AND SAFETY ISSUES

      Cardiovascular drugs and therapy
    53. OPIE LH
      EFFICACY AND TOLERABILITY OF NISOLDIPINE COAT-CORE FORMULATION IN THETREATMENT OF ESSENTIAL-HYPERTENSION - THE SOUTH-AFRICAN MULTICENTER ANCHOR STUDY (VOL 10, PG 250, 1997)

      American journal of hypertension
    54. OPIE LH
      CALCIUM-CHANNEL BLOCKERS FOR HYPERTENSION - DISSECTING THE EVIDENCE FOR ADVERSE-EFFECTS

      American journal of hypertension
    55. OPIE LH; MULLER FO; MYBURGH DP; ROSENDORFF C; SARELI P; SEEDAT YK; WELCH DJV; LUUS HG
      EFFICACY AND TOLERABILITY OF NISOLDIPINE COAT-CORE FORMULATION IN THETREATMENT OF ESSENTIAL-HYPERTENSION - THE SOUTH-AFRICAN MULTICENTER ANCHOR STUDY

      American journal of hypertension
    56. OPIE LH; HESSE B
      RADIONUCLIDE TRACERS IN THE EVALUATION OF RESTING MYOCARDIAL-ISCHEMIAAND VIABILITY

      European journal of nuclear medicine
    57. OPIE LH
      PRECONDITIONING - WE DO NOT NEED MORE EXPERIMENTS, BECAUSE OUR CURRENT KNOWLEDGE ALREADY PERMITS US TO DEVELOP PHARMACOLOGICAL AGENTS

      Basic research in cardiology
    58. MOOLMAN JA; GENADE S; TROMP E; OPIE LH; LOCHNER A
      ISCHEMIC PRECONDITIONING DOES NOT PROTECT HYPERTROPHIED MYOCARDIUM AGAINST ISCHEMIA

      South African medical journal
    59. LOCHNER A; HUISAMEN B; KLOPPER JF; OPIE LH; KING L; DUTOIT EF
      MYOCARDIAL-METABOLISM .2. DISCUSSION

      South African medical journal
    60. LOCHNER A; HUISAMEN B; KLOPPER JF; OPIE LH; KING L; DUTOIT EF
      MYOCARDIAL-METABOLISM .1. ROUND-TABLE DISCUSSION

      South African medical journal
    61. OPIE LH
      PHARMACOLOGICAL DIFFERENCES BETWEEN CALCIUM-ANTAGONISTS

      European heart journal
    62. OPIE LH
      MECHANISMS WHEREBY CALCIUM-CHANNEL ANTAGONISTS MAY PROTECT PATIENTS WITH CORONARY-ARTERY DISEASE

      European heart journal
    63. OPIE LH; LUSCHER TF; FERRARI R; HANSEN JF
      HOW EUROPEAN CARDIOLOGISTS PERCEIVE THE ROLE OF CALCIUM-ANTAGONISTS IN FOLLOW-UP AFTER MYOCARDIAL-INFARCTION

      European heart journal
    64. MEYER C; NIELSEN FS; SATO A; HOVE JD; HOLM S; KOFOED KF; KELBAEK H; OPIE LH; PARVING HH; HESSE B
      BENEFICIAL EFFECT OF ACUTE ACE-INHIBITION ON VASOMOTION AND MYOCARDIAL PERFUSION IN TYPE-II DIABETICS WITH LEFT-VENTRICULAR HYPERTROPHY

      Circulation
    65. AWAN MM; OPIE LH; YELLON DM
      INADVERTENT PRECONDITIONING - IS IT INEVITABLE

      Circulation
    66. OPIE LH
      NEW DEVELOPMENTS IN THE CALCIUM-CHANNEL ANTAGONIST CONTROVERSY

      Circulation
    67. OPIE LH
      WHAT DOES NISOLDIPINE COAT CORE (CC) ADD TO CURRENT THERAPY THAT IS CLINICALLY MEANINGFUL

      The American journal of cardiology
    68. SOWERS JR; FRISHMAN WH; ZANCHETTI A; OPIE LH; HOBBS FDR; EPSTEIN M; MESSERLI FH
      CARDIAC EFFECTS OF CALCIUM-ANTAGONISTS IN SYSTEMIC HYPERTENSION - DISCUSSION

      The American journal of cardiology
    69. OPIE LH
      CALCIUM-CHANNEL ANTAGONISTS SHOULD BE AMONG THE FIRST-LINE DRUGS IN THE MANAGEMENT OF CARDIOVASCULAR-DISEASE

      Cardiovascular drugs and therapy
    70. OPIE LH
      THE STONE STUDY (SHANGHAI TRIAL OF HYPERTENSION IN THE ELDERLY) - A MEETING REPORT

      Cardiovascular drugs and therapy
    71. OPIE LH
      ACE-INHIBITORS IN PREGNANCY - HOW TO AVOID THE STING IN THE TAIL

      South African medical journal
    72. OPIE LH
      HYPERTENSION 1996 - SIMPLIFIED GUIDELINES FOR PRIMARY-CARE NURSES ANDMEDICAL-STUDENTS

      South African medical journal
    73. OPIE LH; STEYN K
      HYPERTENSION MANAGEMENT - AN ALGORITHM

      South African medical journal
    74. OPIE LH
      HYPERTENSION MANAGEMENT GUIDELINES - REPLY

      South African medical journal
    75. OPIE LH
      INTRODUCTION

      Journal of cardiovascular pharmacology
    76. OPIE LH
      CALCIUM-CHANNEL ANTAGONISTS IN THE TREATMENT OF CORONARY-ARTERY DISEASE - FUNDAMENTAL PHARMACOLOGICAL PROPERTIES RELEVANT TO CLINICAL USE

      Progress in cardiovascular diseases
    77. OPIE LH
      CALCIUM-CHANNEL ANTAGONISTS IN THE MANAGEMENT OF ANGINAL SYNDROMES - CHANGING CONCEPTS IN RELATION TO THE ROLE OF CORONARY VASOSPASM

      Progress in cardiovascular diseases
    78. KING LM; OPIE LH
      DOES PRECONDITIONING ACT BY GLYCOGEN DEPLETION IN THE ISOLATED RAT-HEART

      Journal of Molecular and Cellular Cardiology
    79. OPIE LH
      THE MULTIFARIOUS SPECTRUM OF ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION - RELEVANCE OF NEW ISCHEMIC SYNDROMES

      Journal of Molecular and Cellular Cardiology
    80. CROSS HR; OPIE LH; RADDA GK; CLARKE K
      IS A HIGH GLYCOGEN-CONTENT BENEFICIAL OR DETRIMENTAL TO THE ISCHEMIC RAT-HEART - A CONTROVERSY RESOLVED

      Circulation research
    81. BRUNNER F; OPIE LH
      ENDOTHELIN SUBTYPE-A RECEPTORS MEDIATE ENDOTHELIN-1 EFFECTS ON ISCHEMIC CONTRACTURE AND REPERFUSION FUNCTION IN THE RAT

      Circulation
    82. PODZUWEIT T; VANROOYEN J; THOMAS S; MULLER A; OPIE LH
      MECHANISMS OF CAMP INCREASE IN THE ISCHEMIC RAT-HEART - ADENYLYL-CYCLASE VS PHOSPHODIESTERASE

      Circulation
    83. OPIE LH
      NEW CONCEPTS REGARDING EVENTS THAT LEAD TO MYOCARDIAL-INFARCTION

      Cardiovascular drugs and therapy
    84. OPIE LH
      CHRONIC STUNNING - THE NEW SWITCH IN THOUGHT

      Basic research in cardiology
    85. OPIE LH
      RISK-FACTORS FOR HEART-DISEASE

      South African medical journal
    86. OPIE LH
      REGULATION OF MYOCARDIAL-CONTRACTILITY

      Journal of cardiovascular pharmacology
    87. FRICK MH; OPIE LH; PAPP JG
      CALCIUM SENSITIZATION VIA TROPONIN-C - A NEW APPROACH FOR THE TREATMENT OF HEART-FAILURE - PROCEEDINGS OF AN INTERNATIONAL-SYMPOSIUM IN ASSOCIATION WITH THE JOINT XIITH WORLD CONGRESS OF CARDIOLOGY AND XVITH CONGRESS OF THE EUROPEAN-SOCIETY-OF-CARDIOLOGY, SEPTEMBER 10, 1994, BERLIN, GERMANY - PREFACE

      Journal of cardiovascular pharmacology
    88. BRUNNER F; MOUTON R; LOCHNER A; OPIE LH
      DEFECTIVE STRETCH-INDUCED RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE FROM AGING HYPERTENSIVE RAT-HEART - POSSIBLE ROLE OF PHOSPHATIDYLINOSITOL PATHWAY

      Journal of cardiovascular pharmacology
    89. OPIE LH
      RISKS AND BENEFITS OF CALCIUM-ANTAGONISTS

      Lancet
    90. OPIE LH
      GLUCOSE AND THE METABOLISM OF ISCHEMIC MYOCARDIUM

      Lancet
    91. CROSS HR; CLARKE K; OPIE LH; RADDA GK
      IS LACTATE-INDUCED MYOCARDIAL ISCHEMIC-INJURY MEDIATED BY DECREASED PH OR INCREASED INTRACELLULAR LACTATE

      Journal of Molecular and Cellular Cardiology
    92. KING LM; BOUCHER F; OPIE LH
      CORONARY FLOW AND GLUCOSE DELIVERY AS DETERMINANTS OF CONTRACTURE IN THE ISCHEMIC MYOCARDIUM

      Journal of Molecular and Cellular Cardiology
    93. BRUNNER F; STESSEL H; WATZINGER N; LOFFLER BM; OPIE LH
      BINDING OF ENDOTHELIN TO PLASMA-PROTEINS AND TISSUE RECEPTORS - EFFECTS ON ENDOTHELIN DETERMINATION, VASOACTIVITY, AND TISSUE KINETICS

      FEBS letters
    94. OPIE LH; MESSERLI FH
      NIFEDIPINE AND MORTALITY - GRAVE DEFECTS IN THE DOSSIER

      Circulation
    95. OPIE LH; KOWOLIK H
      THE DISCOVERY OF CAPTOPRIL - FROM LARGE ANIMALS TO SMALL MOLECULES

      Cardiovascular Research
    96. OPIE LH; BOUCHER F
      TRIMETAZIDINE AND MYOCARDIAL ISCHEMIC CONTRACTURE IN ISOLATED RAT-HEART

      The American journal of cardiology
    97. OPIE LH
      FUNDAMENTAL ROLE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE MANAGEMENT OF CONGESTIVE-HEART-FAILURE

      The American journal of cardiology
    98. THADANI U; OPIE LH
      NITRATES FOR UNSTABLE ANGINA

      Cardiovascular drugs and therapy
    99. ENOUS R; OPIE LH
      EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, PERINDOPRILAT,AND OF ANGIOTENSIN-II ON THE TRANSIENT INWARD CURRENT OF RABBIT VENTRICULAR MYOCYTES

      Cardiovascular drugs and therapy
    100. OPIE LH
      1993 REFEREE OF THE YEAR AWARD

      Cardiovascular drugs and therapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 04:28:36